UnitedHealth Group Inc (UNH) : Deltec Asset Management reduced its stake in UnitedHealth Group Inc by 0.1% during the most recent quarter end. The investment management company now holds a total of 47,650 shares of UnitedHealth Group Inc which is valued at $6,751,052 after selling 50 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.UnitedHealth Group Inc makes up approximately 1.62% of Deltec Asset Management’s portfolio.
Other Hedge Funds, Including , Conning boosted its stake in UNH in the latest quarter, The investment management firm added 140 additional shares and now holds a total of 35,915 shares of UnitedHealth Group Inc which is valued at $5,088,437. UnitedHealth Group Inc makes up approx 0.21% of Conning’s portfolio.Catawba Capital Management Va boosted its stake in UNH in the latest quarter, The investment management firm added 340 additional shares and now holds a total of 3,515 shares of UnitedHealth Group Inc which is valued at $502,715. UnitedHealth Group Inc makes up approx 0.12% of Catawba Capital Management Va’s portfolio.Leavell Investment Management reduced its stake in UNH by selling 111 shares or 0.4% in the most recent quarter. The Hedge Fund company now holds 27,604 shares of UNH which is valued at $3,947,924. UnitedHealth Group Inc makes up approx 0.57% of Leavell Investment Management’s portfolio.Churchill Management Corp reduced its stake in UNH by selling 1,883 shares or 5.72% in the most recent quarter. The Hedge Fund company now holds 31,022 shares of UNH which is valued at $4,382,478. UnitedHealth Group Inc makes up approx 0.28% of Churchill Management Corp’s portfolio.
UnitedHealth Group Inc opened for trading at $141.85 and hit $143.895 on the upside on Friday, eventually ending the session at $143.2, with a gain of 0.31% or 0.44 points. The heightened volatility saw the trading volume jump to 32,69,716 shares. Company has a market cap of $136,155 M.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.